$0.5184
At close: Jul 17 EDT
Comments
Loading...
Gemina Laboratories Analyst Ratings and Price Targets | OTC:GLABF | Benzinga
Gemina Laboratories Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Gemina Laboratories Corp from these most-recent analyst ratings.
Analyst Ratings for Gemina Laboratories
Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Gemina Laboratories (GLABF) stock?
There is no price target for Gemina Laboratories
What is the most recent analyst rating for Gemina Laboratories (GLABF)?
There is no analyst for Gemina Laboratories
When was the last upgrade for Gemina Laboratories (GLABF)?
There is no last upgrade for Gemina Laboratories
When was the last downgrade for Gemina Laboratories (GLABF)?
There is no last downgrade for Gemina Laboratories.
When is the next analyst rating going to be posted or updated for Gemina Laboratories (GLABF)?
There is no next analyst rating for Gemina Laboratories.
Is the Analyst Rating Gemina Laboratories (GLABF) correct?
There is no next analyst rating for Gemina Laboratories.
Browse analyst ratings and price targets on all stocks.
